Patient adherence to treatment can sometimes be tricky—especially when out-of-pocket costs are considered.
Diabetic Eye Awareness
When it comes to diabetic eye diseases, there are a multitude of potential treatments—but perhaps the “easiest” one for patients is to ensure their A1C levels are under control.1
Proliferative diabetic retinopathy (PDR) is defined by the presence of neovascularization; the use of ultra-widefield (UWF) imaging has shown the distribution of this neovascularization and other diabet
The most consistent means to lower the risk of developing complications from diabetes is for people to maintain good glycemic control.1 The new current criteria for the diagnosis of diabetes now in
November is once again being recognized as Diabetic Eye Disease Awareness Month in an effort to educate the public on the effects of diabetes on vision, risk factors and treatment options.
From the latest ADA position statements to special issues to dietary intake, here’s the latest info to share with your patients about diabetic eye disease.
About 33% of patients with diabetes have diabetic retinopathy (DR), and, of those, 7% will progress to diabetic macular edema (DME).1 Patients with DR and/or DME incur significant medical costs.